Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Effects of a Daily Prebiotic Fibre Blend on Inflammation, the Gut Microbiome, and Self-Report Measures of Mental Health in Individuals With Metabolic Syndrome

NCT06216626 is registered in ClinicalTrials.gov with Myota GmbH as lead sponsor.

NCT NCT06216626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06216626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Effects of a Daily Prebiotic Fibre Blend on Inflammation, the Gut Microbiome, and Self-Report Measures of Mental Health in Individuals With Metabolic Syndrome
Lead sponsor
Myota GmbH
Phase
Not applicable
Overall status
Completed
Start date
June 19, 2023
Completion date
December 22, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, metabolic syndrome, mood, stress